These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39204216)

  • 1. Insights into the Naso-Oropharyngeal Bacterial Composition in Suspected SARS-CoV-2 Cases.
    Atencio LA; Quintero IJ; Almanza A; Eskildsen G; Sánchez-Gallego J; Herrera M; Fernández-Marín H; Loaiza JR; Mejía LC
    Pathogens; 2024 Jul; 13(8):. PubMed ID: 39204216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
    Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
    Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metatranscriptomic analysis revealed
    Lu S; Zhou Y; Hu Y; Wang J; Li H; Lin Y; Wang D; Xian J; Zhao S; Ma J; Zhu Z; Yang S; Meng Q; Kang Y; Chen B; Li W
    Front Cell Infect Microbiol; 2023; 13():1161763. PubMed ID: 37333851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.
    Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH
    Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal Microbiome Analysis in Patients with Varying SARS-CoV-2 Infection Severity: A Prospective Cohort Study.
    Siasios P; Giosi E; Ouranos K; Christoforidi M; Dimopoulou I; Leshi E; Exindari M; Anastassopoulou C; Gioula G
    J Pers Med; 2024 Mar; 14(4):. PubMed ID: 38672996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 genetic variation and bacterial communities of naso-oropharyngeal samples in middle-aged and elderly COVID-19 patients in West Java, Indonesia.
    Adzdzakiy MM; Sutarno S; Asyifa IZ; Sativa AR; Fiqri ARA; Fibriani A; Ristandi RB; Ningrum RA; Iryanto SB; Prasetyoputri A; Dharmayanthi AB; Saputra S
    J Taibah Univ Med Sci; 2024 Feb; 19(1):70-81. PubMed ID: 37868100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.
    Ma S; Zhang F; Zhou F; Li H; Ge W; Gan R; Nie H; Li B; Wang Y; Wu M; Li D; Wang D; Wang Z; You Y; Huang Z
    Signal Transduct Target Ther; 2021 May; 6(1):191. PubMed ID: 33986253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients.
    Gao M; Wang H; Luo H; Sun Y; Wang L; Ding S; Ren H; Gang J; Rao B; Liu S; Wang X; Gao X; Li M; Zou Y; Liu C; Yuan C; Sun J; Cui G; Ren Z
    Adv Sci (Weinh); 2021 Oct; 8(20):e2102785. PubMed ID: 34423593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities.
    Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D
    Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metatranscriptomic Analysis Reveals Disordered Alterations in Oropharyngeal Microbiome during the Infection and Clearance Processes of SARS-CoV-2: A Warning for Secondary Infections.
    Zhou Y; Lu S; Wei X; Hu Y; Li H; Wang J; Lin Y; Li M; Wang M; Ma J; Zhu Z; Yang S; Ying B; Zhang W; Chen B; Li W
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
    Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients.
    Wu J; Liu W; Zhu L; Li N; Luo G; Gu M; Peng M; Zeng S; Wu S; Zhang S; Chen Q; Cai M; Cao W; Jiang Y; Luo C; Tian D; Shi M; Shu Y; Chang G; Luo H
    J Med Virol; 2023 Apr; 95(4):e28727. PubMed ID: 37185870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    de Castilhos J; Zamir E; Hippchen T; Rohrbach R; Schmidt S; Hengler S; Schumacher H; Neubauer M; Kunz S; Müller-Esch T; Hiergeist A; Gessner A; Khalid D; Gaiser R; Cullin N; Papagiannarou SM; Beuthien-Baumann B; Krämer A; Bartenschlager R; Jäger D; Müller M; Herth F; Duerschmied D; Schneider J; Schmid RM; Eberhardt JF; Khodamoradi Y; Vehreschild MJGT; Teufel A; Ebert MP; Hau P; Salzberger B; Schnitzler P; Poeck H; Elinav E; Merle U; Stein-Thoeringer CK
    Clin Infect Dis; 2022 Aug; 75(1):e1063-e1071. PubMed ID: 34694375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection.
    Romani L; Del Chierico F; Pane S; Ristori MV; Pirona I; Guarrasi V; Cotugno N; Bernardi S; Lancella L; Perno CF; Rossi P; Villani A; Campana A; Palma P; Putignani L;
    Microbiol Spectr; 2024 Mar; 12(3):e0300923. PubMed ID: 38289047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viable SARS-CoV-2 in various specimens from COVID-19 patients.
    Jeong HW; Kim SM; Kim HS; Kim YI; Kim JH; Cho JY; Kim SH; Kang H; Kim SG; Park SJ; Kim EH; Choi YK
    Clin Microbiol Infect; 2020 Nov; 26(11):1520-1524. PubMed ID: 32711057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.
    Rizzello F; Viciani E; Gionchetti P; Filippone E; Imbesi V; Melotti L; Dussias NK; Salice M; Santacroce B; Padella A; Velichevskaya A; Marcante A; Castagnetti A
    Front Cell Infect Microbiol; 2024; 14():1352202. PubMed ID: 38510960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.